Tag: Sanofis
SANOFI’S QUOTE RESERVED FOR DOWNWARDS
Published on 10/27/2023 at 9:04 a.m. STOCK MARKET – SANOFI QUOTE RESERVED FOR A DROP AFTER THE ANNOUNCEMENT OF AN IPO PROJECT BY…
Sanofi: The market cold-blooded by Sanofi’s strategic plan, the stock suffered a historic fall of 18.93%
(BFM Bourse) – The pharmaceutical group plunged on the Paris Stock Exchange after publishing results lower than expectations in the third quarter. But above all, the company has delivered a…
Sanofi: Sanofi’s Dupixent on track to treat smokers’ bronchitis
(BFM Bourse) – The pharmaceutical group presented positive results on Sunday in the treatment of chronic obstructive pulmonary disease at an international congress. Fitch, for its part, raised Sanofi’s credit…
Bronchiolitis: Sanofi’s vaccine, “a real clinical advance”, assures the president
Where are we after the electroshock of Covid-19? Emmanuel Macron has made the repatriation of drug production a priority. Three years later, shortages in pharmacies were noted this winter with…
Covid-19: Sanofi’s vaccine finally approved by the EU
LThe vaccine against Covid-19 from the French laboratory Sanofi can therefore be used as a booster dose. After two years of waiting and many twists and turns, the European Medicines…
Covid-19: Sanofi’s vaccine finally approved by the European Medicines Agency
DECRYPTION – The French laboratory’s vaccine, which was originally due to be available in June 2021, has racked up setbacks. It will be used as a reminder regardless of the…
Sanofi’s Covid-19 vaccine approved by Europe
The wait will have been long. Almost three years after the outbreak of SARS-CoV-2, Sanofi has just obtained the green light from European regulators for the use of its vaccine…
On the occasion of the EASD, BIOCORP announces the CE marking of SoloSmart®, a medical device intended for SANOFI’s Solostar® pens – 09/19/2022 at 07:30
• Obtaining regulatory approval opens the door to bringing SoloSmart® to market in the European Union Issoire (France), September 19, 2022, 7:30 a.m. CEST – BIOCORP (FR0012788065 – ALCOR /…
Another good inflation figure in the United States, but the Cac 40 remained riveted on Sanofi’s blood pressure monitor
A fall of nearly 14% to the low of this session, a plunge of 20% in just three days, or more than 20 billion euros in market capitalization vanished into…
Asthma in children: Sanofi’s Dupixent approved by the European Commission
French pharmaceutical giant Sanofi announced on Thursday the European Commission’s approval of its drug Dupixent to treat severe asthma in children aged 6 to 11. “The European Commission (EC) has…
Sanofi’s anti-Covid vaccine finally ready
The French laboratory is preparing to request authorization from the regulatory authorities. It’s time for relief at Sanofi. With almost a year late, his vaccine against the Covid is finally…
Sanofi’s Board of Directors proposes the appointment of Carole Ferrand, Emile Voest and Antoine Yver as independent directors – 02/22/2022 at 6:32 p.m.
Sanofi’s Board of Directors proposes the appointment of Carole Ferrand, Emile Voest and Antoine yver as independent directors Paris , the February 22, 2022 . During its meeting of February…